Search
for
Sort by
Research 331–360 of 1000+
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Dengue Virus Infects Primary Human Hair Follicle Dermal Papilla Cells
- Rethinking regeneration: empowerment of stem cells by inflammation
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review
- The role of vasoactive peptides in skin homeostasis—focus on adiponectin and the kallikrein-kinin system
- Treatment of Severe Alopecia Areata: Combination Therapy Using Systemic Cyclosporine A with Low Dose Corticosteroids
- Evaluation of SALT score severity in correlation with trichoscopic findings in alopecia areata: a study of 303 patients
- Differential effects of Wnt5a on the proliferation, differentiation and inflammatory response of keratinocytes
- “Nail loss after teriflunomide treatment: A new potential adverse event”
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- A Cell Membrane-Level Approach to Cicatricial Alopecia Management: Is Caveolin-1 a Viable Therapeutic Target in Frontal Fibrosing Alopecia?
- Reply to ‘CD123 immunohistochemistry for plasmacytoid dendritic cells is useful in the diagnosis of scarring alopecia’: three PDC-related parameters are useful in differentiating lupus alopecia from LPP
- Alopecia Universalis Following Two Sequential Traffic Accidents : Possible Association with Increased Th1 and Th17 Cells and Decreased Th2 Cells
- Oxidative stress and alopecia areata
- Towards a consensus potency assay for mesenchymal stromal cells: a matrix analysis of cell source, donor variability and inflammatory stimuli to refine surrogate markers of immunomodulation
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Increase in IL-15 levels in patients with alopecia areata
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy
- Partial regrowth of scalp hair in a patient treated with extracorporeal pholtochemotherapy and interferon ? 2a
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- ROS-scavenging microneedles loaded with <i>Portulaca oleracea</i> L.-derived exosomes for atopic dermatitis therapy
- Mechanism of PPARα agonist in alopecia areata
- Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata
- The role of vitamin D in alopecia areata
- British Cosmetic Dermatology Group